[144] Atlanta Braves Holdings, Inc. Series C SEC Filing

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. (BATRK) reported a Rule 144 notice for the proposed sale of 40,000 shares of Series C common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $1,760,800.00. The filing shows the same 40,000 shares were acquired and paid for on 08/15/2025 by exercise of stock options and paid in cash, and no sales by the reporting person were reported in the prior three months.

The notice includes the standard representation that the seller does not possess undisclosed material adverse information. Outstanding shares are listed as 51,459,265, which provides context for the size of the transaction versus the company’s share base.

Positive

• Transaction disclosed under Rule 144, providing regulatory transparency
• Shares were acquired by exercise of stock options and paid in cash on the same date, clarifying the source of the shares
• No reported sales in the prior three months, indicating this is an isolated transaction

Negative

• Sale increases available float by 40,000 shares (~0.08% of outstanding shares), a small but incremental increase in supply

Insights

Securities Analyst

TL;DR A small, routine insider sale following option exercise is disclosed under Rule 144; it appears non-material to share capital.

This Form 144 records a sale of 40,000 Series C shares valued at $1.76 million arising from a same-day option exercise and cash payment. Relative to the reported 51.46 million shares outstanding, the shares represent roughly 0.08% of the float, suggesting limited dilution or market impact. The use of UBS as broker and the seller’s attestation regarding material non-public information are standard compliance measures.

Corporate Governance Expert

TL;DR Disclosure aligns with insider trading rules; transaction mechanics indicate standard executive liquidity rather than corporate change.

The filing shows proper procedural disclosure for a sale following option exercise and immediate cash payment. There is no indication of additional sales in the past three months, and the seller affirms no undisclosed material adverse information. From a governance perspective, this is a routine transparency event rather than a sign of governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series C Common Stock	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	40000	1760800.00	51459265	08/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series C Common Stock	08/15/2025	Exercise of stock options	Issuer			40000	08/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Atlanta Braves Holdings (BATRK) disclose in this Form 144?

The filing notifies a proposed sale of 40,000 Series C common shares through UBS with aggregate market value of $1,760,800, acquired and paid for by option exercise on 08/15/2025.

Who is the broker handling the sale for BATRK Form 144?

The broker named in the filing is UBS Financial Services, Inc., 11 Madison Avenue, New York, NY.

When were the shares acquired and how were they paid for?

The 40,000 shares were acquired on 08/15/2025 by exercise of stock options and paid for in cash on the same date.

How large is the sale relative to outstanding shares?

The filing lists 51,459,265 shares outstanding; the 40,000-share sale represents about 0.08% of that total.

Were any securities sold by the reporting person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.